Salute e Benessere

Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions…

Secondary Immunodeficiencies, particularly in patients with B-cell hematological malignancies, represent a significant clinical challenge due to their complex pathogenesis and the increased risk of life-threatening infections. Advances in cancer therapies have improved survival, but complications, in particular Hypogammaglobulinemia and infections, can compromise treatment outcomes and patient quality of life. Early diagnosis and appropriate management, including Immunoglobulin replacement…
PR Newswire
06/11/2025

Sironax Announces Three Abstracts Selected for Presentation at Neuroscience…

Society for Neuroscience Annual Meeting, November 15-19, San Diego, CA Neuroscience 2025, the Society for Neuroscience annual meeting in San Diego from November 15 to 19.Presentation details are below: Title : Development of a Highly Potent, Brain Penetrant and Allosteric RIPK1 Inhibitor for the Treatment of Neurodegenerative Diseases Session Name : Alzheimer's Disease Therapeutic Strategies: Pharmaceutical Approaches Session Number : PSTR157 Date/Time : November 17, 8 a.m. -12 p...
Nasdaq GlobeNewswire
06/11/2025

Urteste S.A. launches European multicenter clinical study of the Panuri test

Urteste S.A. launches European multicenter clinical study of the Panuri test Gdańsk, Poland – 6 November 2025 – Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in the development of innovative technology for the early detection of cancer from urine samples, has entered into a tripartite agreement with Aurevia Poland and Aurevia Oy, based in Finland, for CRO services, including the organization and management of a European clinical study of the Panuri test — an IVD...
Nasdaq GlobeNewswire
06/11/2025

Evaxion announces business update and third quarter 2025 financial results

/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces third quarter 2025 financial results. Business highlights (since last quarterly update)Evaxion has seen tremendous progress in recent months with several massive achievements. We maintain a high activity level and continue to execute our plans. Highlights include: Evaxion’s Board of Directors has appointed Dr Helen...
Nasdaq GlobeNewswire
06/11/2025

Designing for Tomorrow: The 138th Canton Fair Showcases Innovations Rooted in…

Technology, meanwhile, is redefining what safety can mean in daily family life. One of the innovations at this session came from an Anhui-based company introducing an intelligent baby crib equipped with an automated rocking system that responds to a child's cry. The design not only provides hands-free comfort for parents but also extends usability from infancy up to three years of age, showcasing a thoughtful balance between convenience, safety, and functionality. Technology, meanwhile, is...
PR Newswire
06/11/2025

uniQure to Announce Third Quarter 2025 Financial Results

~ uniQure to host earnings call on Monday, November 10, 2025 at 8:30 a.m. ET ~ uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report third quarter 2025 financial results before market open on Monday, November 10, 2025. Management will then host a conference call at 8:30 a.m. ET.The event will be webcast under the Events & Presentations section of uniQure’s website athttps://www.uniqure...
Nasdaq GlobeNewswire
06/11/2025

TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of…

First study to report promising activity for an active immunotherapy combined with TAS-102 (LONSURF®) in late-stage MSS mCRC; TREOS advances Phase II programme with Charité – Universitätsmedizin Berlin and Junshi Biosciences Journal of Clinical Oncology - Oncology Advances of results from OBERTO-201 (NCT05130060), a Phase 1b study evaluating PolyPEPI1018, an off-the-shelf multi-peptide immunotherapy, in combination with oral chemotherapy TAS-102 (LONSURF®) for patients with refractory...
Nasdaq GlobeNewswire
06/11/2025

SkylineDx Wins 2025 BioTech Breakthrough Award for "Diagnostics Company of the…

The Merlin CP-GEP Test is a genomic assay that guides disease management decisions across all stages of melanoma and is available commercially in the U.S. and Europe. The Merlin GP-GEP Test combines clinicopathologic factors with gene expression analysis to assess a patient's risk of melanoma metastases. SkylineDx recently published a landmark study in JAMA Surgery validating Merlin CP-GEP Test's ability to accurately stratify melanoma patients by sentinel node metastasis risk, making it a…
PR Newswire
06/11/2025

The 138th Canton Fair Concludes Successfully

Exhibiting enterprises pursued innovation, intelligence and environment protection in materials, craftsmanship and supply chains. New and green products and products with independent intellectual property rights accounted for 23.3%, 23.5% and 23.9% of the total 4.6 million products respectively. AI empowerment, innovative and intelligent manufacturing, low-carbon and high-end customization were the key words throughout three phases. Humanoid robots, brain-computer interface devices, plastic-free…
PR Newswire
06/11/2025

Health and Fitness Club Market to Reach $102.3 Billion by 2024 in the short term…

Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A11813 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A11813 Market Introduction: The health and fitness club market includes a broad range of services meant to enhance general well-being, physical health, and quality of life. These clubs include wellness centers, boutique fitness studios, conventional gyms, and specialty training facilities...
PR Newswire
06/11/2025

Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30

Tigermed's selection demonstrates the growing global impact of China's biopharmaceutical innovation. As a global clinical development services provider, Tigermed operates more than 180 offices and networks worldwide with over 10,000 across North America, Europe, China, Asia-Pacific, Africa and Latin-America. We are devoted to building an integrated end-to-end platform that enables the boundless possibilities for the healthcare industry, and becoming a bridge for China biotech…
PR Newswire
06/11/2025

Novonesis delivered 8% organic sales growth in the first nine months of 2025

Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine months of 2025. Full-year outlook is narrowed upwards to 7-8%, previously 6-8%.Ester Baiget, President & CEO: "I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability. Our performance was strong...
Nasdaq GlobeNewswire
06/11/2025

arcoris bio raises CHF 6.3 million seed round to advance next-generation…

Round co-led by Ventura Ace and ZEISS Ventures, with participation from Zürcher Kantonalbank (ZKB) and new as well as existing private investors.MUSE ®, arcoris bio’s nanotechnology platform for biomarker detection and signal amplification, enables simultaneous detection of multiple biomarkers with unprecedented ease and sensitivity.The funding will accelerate industrialization of the MUSE ®platform, expansion of strategic partnerships, and launch of new products.Schlieren,...
Nasdaq GlobeNewswire
06/11/2025

Nucleome Therapeutics founder Professor James Davies and Oxford University…

Dr. Mark Bodmer, CEO of Nucleome, commented: "Congratulations to James and his team at Oxford on this groundbreaking work. Using MCC technology, for the first time it has been possible to see 3D interactions in the nucleus inside the cell at base pair resolution. This gives us a new way of looking at how genetic variation in the human genome causes disease. At Nucleome, we are applying this transformative technology to solve the molecular basis of inflammatory diseases. This has enabled us…
PR Newswire
06/11/2025

Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive…

With 30 years of international leadership experience in the MedTech sector across Europe and the U.S., Vincent brings deep expertise in commercial strategy, market expansion, and value creation. He has successfully guided several companies through critical phases of growth and commercialization, including his tenure as CEO of Vexim, where he transformed the spinal implant company from an early-stage venture into a profitable international organization, ultimately leading to a successful IPO and…
PR Newswire
06/11/2025

Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery…

Understanding the challenges of early-stage development, Mabqi and Abzena formed their partnership to offer a solution that enables drug developers to seamlessly bridge from discovery through lead candidate selection into pre-clinical development and beyond. Through this collaboration, customers will benefit from combined scientific and technical support, streamlined workflows, and accelerated development timelines. Understanding the challenges of early-stage development, Mabqi and Abzena...
PR Newswire
06/11/2025

CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to…

The two Groups have reached a binding agreement on the main principles of their collaboration, with a view to deploying a capacity of one million tonnes in the long term,Starting with the construction of a plant in China with a processing capacity of 50,000 tonnes of PET waste per year.This collaboration remains subject to the signing of final agreements.Clermont-Ferrand (France), November 6, 2025 (08:30am CET).Following the Letter of intent signed on June 24, 2024, CARBIOS...
Nasdaq GlobeNewswire
06/11/2025

Kanazawa University research: Protein droplets in the nucleus guard against…

Our genetic material is tightly packed inside the cell nucleus, wrapped around proteins called histones. To keep the right genes active, cells rely on proteins like CHD1, which reorganize this DNA structure when needed. Our genetic material is tightly packed inside the cell nucleus, wrapped around proteins called histones. To keep the right genes active, cells rely on proteins like CHD1, which reorganize this DNA structure when needed. The Kanazawa team led byKatsuya Sakai, discovered...
PR Newswire
06/11/2025

Lunai Bioworks achieves complete regression of both primary and metastatic…

The study was published in a new Brief Report in Vaccines on November 2, 2025. The peer-reviewed Brief Report details the development of a second-generation, clinical-grade DC construct that achieved complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models. Pancreatic cancer is one of the deadliest cancers, often diagnosed late and resistant to conventional treatments. Lunai's therapy uses engineered dendritic cells — specialized immune cells created…
PR Newswire
06/11/2025

8% organic sales growth after first nine months. Full-year organic sales growth…

Ester Baiget, President & CEO:” I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was strong across all sales areas and in Emerging and Developed Markets. We delivered 37.3% adjusted EBITDA margin, despite significant currency headwinds, demonstrating the strength and resilience of our business model. Following a robust nine-months performance including favorable timing in the...
Nasdaq GlobeNewswire
06/11/2025

HSG Laser Unveils Smart Sheet & Tube Cutting Solutions at SMTECH 2025

At Booth 321, Tüyap Fair and Congress Center, HSG LASER showcased flagship machines that highlight its innovation in intelligent laser cutting — combining speed, precision, and automation to elevate industrial efficiency. At Booth 321, Tüyap Fair and Congress Center, HSG LASER showcased flagship machines that highlight its innovation in intelligent laser cutting — combining speed, precision, and automation to elevate industrial efficiency. BridgingEuropeandAsia : Empowering Smart...
PR Newswire
06/11/2025

Interim Report Q3 2025: Solid quarter with 1% organic growth, 11% EBITA margin…

HighlightsThe Hearing division delivered 7% organic revenue growth driven by the continued strong performance of ReSound Vivia, enabling broad-based market share gains. The divisional profit margin ended at 34%, driven by positive operating leverage, but partly offset by negative country mixThe Enterprise division continued to experience positive sell-out growth outside of Europe, driven by strong channel execution and market leading innovation, while Europe continued to be challenged...
Nasdaq GlobeNewswire
06/11/2025

Pharming Group reports third quarter 2025 financial results with significant…

Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting sustained growth in patients and prescribersJoenja® (leniolisib) third quarter revenue increased by 35% to US$15.1 million, compared to third quarter 2024, reflecting strong growth in patients on therapy FDA granted priority review of sNDA for leniolisib...
Nasdaq GlobeNewswire
06/11/2025

138th Canton Fair: Rising Demand for At-Home Healthcare Spurs Innovation in…

The company's founder noted that the Canton Fair marks the first public debut of their products. The decision to showcase them at this global platform was driven by the scale of need it seeks to address, with more than 12 million people worldwide suffering a stroke each year, including over 4 million in China and around 8 million elsewhere. The founder expressed hope that the fair would open doors to overseas channel partners interested in innovative healthcare solutions. Through such…
PR Newswire
06/11/2025
Altri  Comunicati